---
figid: PMC9501262__pharmaceuticals-15-01070-g002
pmcid: PMC9501262
image_filename: pharmaceuticals-15-01070-g002.jpg
figure_link: /pmc/articles/PMC9501262/figure/pharmaceuticals-15-01070-f002/
number: Figure 2
figure_title: ''
caption: Cytotoxic effects of Far-C against human liver cancer HepG2 cells. (A) Cellular
  viability percentage of HepG2 cells and (B) changes in the morphological features
  such as circular morphology (red arrow), disintegrated organelles (orange arrows
  and blue arrows) of HepG2 cells post-24 h exposure with Far-C. Scale bar = 100 Âµm.
  * p < 0.05, ** p < 0.01, *** p < 0.001.
article_title: Farnesiferol C Exerts Antiproliferative Effects on Hepatocellular Carcinoma
  HepG2 Cells by Instigating ROS-Dependent Apoptotic Pathway.
citation: Ahmed Alafnan, et al. Pharmaceuticals (Basel). 2022 Sep;15(9):1070.
year: '2022'

doi: 10.3390/ph15091070
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- farnesiferol C
- HepG2 cells
- ROS
- apoptosis
- intrinsic apoptotic pathway
- caspase-3

---
